Long-Term Prevention and Family Health

Living with Antiphospholipid Syndrome (APS) is about more than just managing a single diagnosis; it is about long-term vigilance and risk reduction. For many patients, the discovery of a genetic clustering leads to a major question: “Should everyone in my family get tested?” Understanding the current medical consensus can help you and your loved ones navigate this without unnecessary stress.

The Rule on Family Screening

If you have been diagnosed with APS, your first-degree relatives (parents, siblings, and children) may naturally worry about their own risk. However, current international guidelines do not recommend routine antibody screening for asymptomatic family members ^[1][2].

Testing is generally only advised if a relative has a “clinical indication”—meaning they have already experienced a blood clot, a stroke at a young age, or specific pregnancy complications ^[1]. Finding antibodies in a healthy person who has never had a symptom can lead to “medical labeling” and unnecessary anxiety without a clear benefit, as many people carry these antibodies their entire lives and never become ill ^[3][4].

Managing the “Asymptomatic Carrier”

Sometimes, a relative is tested incidentally and found to be an aPL carrier (positive for antibodies but no symptoms). In these cases, the goal is not aggressive treatment, but primary prevention.

• Risk Stratification: Doctors look at the “risk profile” of the carrier. High-risk profiles include persistent lupus anticoagulant, double or triple positivity, or persistently moderate/high anticardiolipin or anti-β2GPI levels ^[5].
• Low-Dose Aspirin: For those with a high-risk antibody profile, the European Alliance of Associations for Rheumatology (EULAR) recommends considering low-dose aspirin to help prevent a first clot ^[5]. This is an individualized decision that balances the benefit of prevention against the risk of bleeding ^[6][7].
• No Long-Term Anticoagulation: Persistent antibody positivity alone is not a reason for lifelong blood thinners like Warfarin ^[8][5].

The Importance of Cardiovascular Health

Because APS antibodies make the blood “stickier,” managing traditional heart health risks is twice as important. Traditional risk factors—like smoking, high blood pressure, and high cholesterol—can act as the “second hit” that triggers a clot in someone who is already antibody-positive ^[9][10].

• Blood Pressure & Lipids: Targeted management (often aiming for below 130/80 mm Hg, though this is individualized) and managing cholesterol is crucial to protect the blood vessels ^[5][11].
• Smoking Cessation: Smoking is one of the most significant avoidable triggers for blood clots in APS patients ^[9].

Long-Term Surveillance

If you have thrombotic APS, your life will involve a regular “surveillance” schedule to keep you safe:

1. INR Monitoring: If you are on Warfarin, regular testing is mandatory. The goal is to stay within your “therapeutic range” at least 70% of the time to minimize the risk of both new clots and dangerous bleeding ^[12][13]. Note that lupus anticoagulant can sometimes interfere with PT/INR results. If your INR is unexpectedly unstable, you may need an alternative monitoring method.
2. Blood Counts: Doctors will periodically check your platelet counts. Low platelets (thrombocytopenia) are common in APS and can affect how safely you can use blood thinners ^[14][15].
3. Kidney Checks: Because APS can affect the small vessels in the kidneys, regular monitoring of blood pressure and urine protein is often recommended to catch any changes early ^[1][16].
4. Surgical Planning and Travel: An individualized peri-procedural plan is needed for surgeries. “Bridging” with temporary LMWH is reserved for selected high-risk situations; many dental procedures do not require stopping Warfarin. Long-haul flights do not routinely require bridging; focus on mobility and hydration ^[5]. Never stop or bridge medication yourself without contacting your anticoagulation team.